DEUTSCHE BANK AG\ - EDGE THERAPEUTICS INC ownership

EDGE THERAPEUTICS INC's ticker is EDGE and the CUSIP is 279870109. A total of 43 filers reported holding EDGE THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of EDGE THERAPEUTICS INC
ValueSharesWeighting
Q2 2018$16,000
-44.8%
16,226
-38.2%
0.00%
Q1 2018$29,000
-95.3%
26,255
-60.5%
0.00%
Q4 2017$621,000
-8.0%
66,507
+5.6%
0.00%
Q3 2017$675,000
+202.7%
62,993
+188.1%
0.00%
Q2 2017$223,000
+537.1%
21,862
+457.1%
0.00%
Q1 2017$35,000
-70.6%
3,924
-59.2%
0.00%
Q4 2016$119,000
+340.7%
9,614
+259.5%
0.00%
Q3 2016$27,000
+8.0%
2,674
+7.6%
0.00%
Q2 2016$25,000
+127.3%
2,484
+93.0%
0.00%
Q1 2016$11,000
-57.7%
1,287
-39.2%
0.00%
Q4 2015$26,0002,1160.00%
Other shareholders
EDGE THERAPEUTICS INC shareholders Q2 2018
NameSharesValueWeighting ↓
New Leaf Venture Partners, L.L.C. 2,344,868$21,362,00010.94%
VHCP Management II, LLC 1,933,582$17,615,0007.21%
ACUTA CAPITAL PARTNERS, LLC 1,351,516$12,312,0002.92%
Opaleye Management Inc. 280,000$2,550,0001.27%
SPHERA FUNDS MANAGEMENT LTD. 150,000$1,367,0000.27%
REGENTATLANTIC CAPITAL LLC 135,000$1,230,0000.11%
MARK SHEPTOFF FINANCIAL PLANNING, LLC 15,401$140,0000.10%
TFS CAPITAL LLC 22,993$209,0000.07%
EAGLE ASSET MANAGEMENT INC 899,968$8,198,0000.05%
Trexquant Investment LP 15,669$143,0000.02%
View complete list of EDGE THERAPEUTICS INC shareholders